SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------------------------------
Form 8-K
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): March 14, 2003
OCEAN BIO-CHEM, INC.
(Exact name of registrant as specified in charter)
Florida 2-70197 59-1564329
(State or other (Commission File Number) (IRS Employer
jurisdiction Identification No.)
of Incorporation)
4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
(Address of principal executive office) (Zip Code)
Registrant's telephone number, including area code: 954/587-6280
Item 5. Other Events and Required FD Disclosure.
Two lawsuits previously disclosed by the Company (North American Oil
Company, Inc. v. Star Brite Distributing, Inc., United States District Court for
the North District of Georgia, Atlanta Division, Civil Action No.
1098-CV-1589-RWS and North American Oil Company, Inc. v. Star Brite
Distribuiting, Inc., Docket 02-7120, United States Court of Appeals for the
Second Circuit (on appeal from the United States District Court for the District
of Connecticut, Case No. 3:00-MC-339 (EBB)), have been settled. All claims and
counterclaims have been dismissed with prejudice. The settlement does not affect
the Company's United States Patent No. 5,250,598, which remains valid and
enforceable.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
OCEAN BIO-CHEM, INC.
Date: March 14, 2003 By: /s/ Peter G. Dornau
--------------------------------------
Name: Peter G. Dornau
Title: Chairman of the Board of
Directors and Chief
Executive Officer
Date: March 14, 2003 By: /s/ Edward Anchel
--------------------------------------
Name: Edward Anchel
Title: Chief Financial Officer